Latest Articles
.png)
Pre-Launch Readiness: Building Commercial Infrastructure Before Approval
The commercial organization you build before approval determines what your launch looks like the day after. Why pre-launch infrastructure decisions are the highest-leverage commercial work in life sciences — and what to prioritize when timeline and capital are both constrained.
Market Access Integration: Why It Belongs in Commercial Planning, Not Beside It
Market access decisions made independently of commercial strategy compound into commercial problems at launch. How to integrate market access into commercial planning from the start.
Board-Level Commercial Reporting: What Investors Actually Want to See
How commercial reporting should be structured for board and investor audiences — and the most common ways commercial leaders get this wrong.
Building a 150-Person Commercial Organization From Three
Practical lessons from scaling a commercial organization from inception through first-in-class launch — function by function, hire by hire.
.png)
In-Licensing Strategy: Diligence Beyond the Term Sheet
The commercial diligence questions that materially affect in-licensing outcomes — and the questions term-sheet-driven diligence often misses.
Fractional vs. Full-Time CCO: Choosing the Right Commercial Leadership Structure
When fractional commercial leadership is the right answer, when it isn’t, and how to structure either engagement for outcomes that compound.
Senior Commercial Perspectives, In Your Inbox
Get ISG’s perspectives on life sciences commercial strategy — capital formation, launch, business development, and the leadership decisions that define enterprise value.
Ready to Talk About Your Specific Inflection Point?
Articles can frame the question. A diagnostic conversation answers it.